AMC CNS - Detection of Central Nervous System Infections

Description

Detection of Central Nervous System Infections

AMC CNS is a clinical analysis to detect potential infections in the central nervous system (CNS). The analysis detects all microorganisms present in the cerebrospinal fluid (CSF) sample, enabling the identification of all pathogenic microorganisms.

Microorganisms Detected

Complete detection of viruses and other pathogens causing CNS infections.

• Herpesviruses (HSV 1, 2, 6, 7, 8)
• Varicella-zoster virus
• Epstein-Barr virus
• Cytomegalovirus (CMV)
• Other pathogenic microorganisms

Detectable Pathologies

Serious CNS infections requiring early detection to avoid sequelae.

• Encephalitis
• Meningitis
• Meningoencephalitis
• Lethal CNS infections
• Infections with serious sequelae

Sample Analyzed

• Cerebrospinal fluid (CSF)
• Detection of all microorganisms present
• Identification of pathogens
• Specialized CNS analysis
• High-precision technology
• Critical results for diagnosis

Advantages of the Analysis

• Crucial early detection
• Prevents lethal consequences
• Avoids significant sequelae
• Specialized CSF analysis
• Rapid identification of pathogens

Microbiota-Brain Communication Pathways

Neural Pathway

• Vagus nerve
• Enteric nervous system
• Microbial neurotransmitters

Endocrine Pathway

• Hypothalamic-pituitary-adrenal axis
• Proinflammatory cytokines
• Bacterial metabolites

Technology

Neuro-specialized Nanopore NGS Technology

We implement Nanopore NGS technology with specialized protocols for the analysis of the microbiota-gut-brain axis, including functional analysis of neurotropic genes and neuroactive metabolic pathways.

Advanced Functional Analysis

• Functional genomics: Neurotransmitter synthesis genes
• Predictive metabolomics: Tryptophan and tyrosine pathways
• Neurological resistome: Resistance to neuropharmaceuticals
• Virulome: Neurotoxicity factors
• Mobilome: Horizontal gene transfer

Neuroimmunological Pipeline

• Database: NeuroMicrobiome DB
• Algorithms: Neurotropic machine learning
• Correlations: Microbiota-neurotransmitters
• Prediction: Neurodegenerative risk
• Personalization: Psychobiotic therapy

Neuroimmunological Biomarkers

Neuroinflammation

• IL-1β, IL-6, TNF-α
• Microglial activation
• Astrocyte markers

Neurotransmission

• GABA synthesis
• Serotonin metabolism
• Dopamine precursors

Neuroprotection

• Microbial BDNF
• Antioxidants
• Trophic factors

Technological Innovation

Our approach integrates multiple omics for a complete view:

• Metagenomics: Identification of neurotropic species
• Metatranscriptomics: Expression of neuro-relevant genes
• Metabolomics: Neuroactive metabolites
• Proteomics: Gut-brain communication proteins
• Pharmacogenomics: Response to psychotropic drugs

Sample

Specialized Collection Protocol

Central nervous system analysis requires cerebrospinal fluid samples and specialized protocols to preserve neuroimmunological biomarkers and maximize diagnostic information.

Cerebrospinal Fluid (CSF)

• Volume: 2-5 mL
• Technique: Sterile lumbar puncture
• Storage: 4°C immediately
• Processing: Within 2 hours
• Transport: Continuous refrigeration

Serum Biomarkers

• Volume: 5 ml serum
• Fasting: 12 hours
• Time: 8:00-10:00 AM
• Storage: -20°C
• Analysis: Cytokines and neurotransmitters

Neuropsychological Questionnaire

Complementary clinical information essential for interpretation:

Neurological History

• Neuropsychiatric diagnoses
• Current medication
• Family history
• Cognitive symptoms

Environmental Factors

• Diet and supplements
• Stress and sleep quality
• Exposure to toxins
• Physical activity

Critical Considerations

• Avoid antibiotics 30 days before sampling
• Do not modify psychiatric medication without medical supervision
• Report probiotic supplements
• Maintain usual dietary routine
• Coordinate collection with the neurological team

Temporal Protocol

• Complete the neuropsychological questionnaire
• Fasting blood draw (8:00-10:00 AM)
• Collection of cerebrospinal fluid (same morning)
• Immediate storage per protocol
• Urgent shipment with dry ice

Results

Comprehensive Neuroimmunological Report

Our report provides a complete assessment of the microbiota-gut-brain axis with predictive analysis of neurodegenerative risk and personalized therapeutic recommendations based on psychobiotics.

Neurotropic Profile

• Neurotransmitter index
• GABAergic potential
• Serotonergic capacity
• Dopaminergic metabolism

Neuroinflammatory Status

• Microglial activation
• Proinflammatory cytokines
• Blood-brain barrier permeability
• Neuronal oxidative stress

Neuroprotection

• Trophic factors
• Antioxidant capacity
• Protective metabolites
• Neuronal resilience

Predictive Analysis

• Alzheimer’s risk: Algorithmic score
• Depressive predisposition: Specific markers
• Anxiety: GABAergic profile
• Parkinson’s: Dopamine metabolism
• Autism: Specific dysbiosis

Pharmacogenomics

• Antidepressants: CYP450 metabolism
• Anxiolytics: GABA response
• Antipsychotics: Metabolization
• Nootropics: Predicted efficacy
• Probiotics: Specific strains

Personalized Psychobiotic Therapy

Depression/Anxiety

• L. helveticus R0052
• B. longum R0175
• L. rhamnosus JB-1

Neurodegeneration

• A. muciniphila
• F. prausnitzii
• B. breve A1

Cognitive Function

• L. plantarum DR7
• B. infantis 35624
• L. casei Shirota

Specialized Neuroclinical Interpretation

Each report includes:

• Assessment of current neuroimmunological status
• Risk analysis for neurodegenerative disorders
• Recommendations for specific psychobiotics
• Neuroprotective nutritional strategies
• Neurobiological follow-up protocol
• Coordination with the neurological/psychiatric team

Clinical indications

Clinical Indications for AMC CNS

Serious CNS Infections

• Viral encephalitis
• Infectious meningitis
• Meningoencephalitis
• Herpesvirus infections
• CMV infections
• Lethal CNS infections
• Infections with risk of sequelae

Target Microorganisms

• Herpesviruses (HSV 1, 2, 6, 7, 8)
• Varicella-zoster virus
• Epstein-Barr virus
• Cytomegalovirus (CMV)
• Other CNS pathogens
• Autism spectrum disorder
• Treatment-resistant ADHD

Neuroinflammation

• Autoimmune encephalitis
• Neurological post-COVID syndrome
• Chronic fatigue
• Fibromyalgia
• Chronic migraine
• Central sensitivity syndrome
• Idiopathic neuroinflammation

Neurodevelopment

• Developmental delay
• Learning disorders
• Attention deficit
• Language disorders
• Refractory epilepsy
• Rett syndrome
• Mitochondrial disorders

Preventive Neurological Medicine

Risk Factors

• Family history of dementia
• APOE-ε4 polymorphisms
• Metabolic syndrome
• Chronic stress
• Sleep disorders

Personalized Prevention

• Preventive microbiota modulation
• Neuroprotective nutrition
• Targeted supplementation
• Biomarker monitoring
• Early intervention

Precision Neurological Medicine

Advanced indications for:

Psychobiotic Therapy

• Selection of specific strains
• Personalized dosing
• Synergistic combinations
• Therapeutic monitoring

Neural Pharmacogenomics

• Optimization of psychotropic drugs
• Prediction of adverse effects
• Dose adjustment
• Combination therapy